<?xml version="1.0" ?>
<document id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701">
  <chunk id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c0" text="viruses Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections">
    <entity charOffset="21-35" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c0.e0" ontology_id="GO_0042783" text="Immune Evasion" type="gene_function"/>
    <entity charOffset="44-56" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c0.e1" ontology_id="GO_0009405" text="Pathogenesis" type="gene_function"/>
  </chunk>
  <chunk id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1" text="Positive-sense single-stranded RNA (+ssRNA) viruses comprise many (re-)emerging human pathogens that pose a public health problem. Our innate immune system and, in particular, the interferon response form the important first line of defence against these viruses. Given their genetic flexibility, these viruses have therefore developed multiple strategies to evade the innate immune response in order to optimize their replication capacity. Already many molecular mechanisms of innate immune evasion by +ssRNA viruses have been identified. However, research addressing the effect of host innate immune evasion on the pathology caused by viral infections is less prevalent in the literature, though very relevant and interesting. Since interferons have been implicated in inflammatory diseases and immunopathology in addition to their protective role in infection, antagonizing the immune response may have an ambiguous effect on the clinical outcome of the viral disease. Therefore, this review discusses what is currently known about the role of interferons and host immune evasion in the pathogenesis of emerging coronaviruses, alphaviruses and flaviviruses.">
    <entity charOffset="369-391" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1.e0" ontology_id="GO_0045087" text="innate immune response" type="gene_function"/>
    <entity charOffset="376-391" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1.e1" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
    <entity charOffset="485-499" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1.e2" ontology_id="GO_0042783" text="immune evasion" type="gene_function"/>
    <entity charOffset="595-609" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1.e3" ontology_id="GO_0042783" text="immune evasion" type="gene_function"/>
    <entity charOffset="881-896" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1.e4" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
    <entity charOffset="1068-1082" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1.e5" ontology_id="GO_0042783" text="immune evasion" type="gene_function"/>
    <entity charOffset="1090-1102" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c1.e6" ontology_id="GO_0009405" text="pathogenesis" type="gene_function"/>
  </chunk>
  <chunk id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c2" text="Viruses 2019, 11, 961 3 of 23 receptor-associated factors 2 and 6 (TRAF2/6). This pathway ultimately leads to the degradation of the inhibitor of kB (IκB) and thereby to the release of NF-κB. The activation of the other two transcription factors is achieved by signalling through TRAF3, which activates two kinases: TRAF family member-associated NF-κB activator binding kinase 1 (TBK1) and inducible IκB kinase ε (IKKε). Active TBK1 and IKKε can phosphorylate IRF3 and IRF7 to promote their translocation to the nucleus [3, 23, 24] . TLR7, which is located in the endosomes, recognizes ssRNA and signals through the myeloid differentiation primary response gene 88 (MyD88) pathway. MyD88 forms a complex with interleukin-1 receptor-associated kinases 1 and 4 (IRAK-4 and IRAK-1) and TRAF6. Next, this complex can activate the transcription factor IRF7 [3,23,24] ( Figure 1A ).">
    <entity charOffset="114-125" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c2.e0" ontology_id="GO_0009056" text="degradation" type="gene_function"/>
    <entity charOffset="261-271" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c2.e1" ontology_id="GO_0023052" text="signalling" type="gene_function"/>
    <entity charOffset="362-369" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c2.e2" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="380-384" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c2.e3" ontology_id="GO_0008384" text="TBK1" type="gene_function"/>
    <entity charOffset="428-432" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c2.e4" ontology_id="GO_0008384" text="TBK1" type="gene_function"/>
    <entity charOffset="512-519" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c2.e5" ontology_id="GO_0005634" text="nucleus" type="gene_function"/>
  </chunk>
  <chunk id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3" text="nucleus [3, 23, 24] . TLR7, which is located in the endosomes, recognizes ssRNA and signals through the myeloid differentiation primary response gene 88 (MyD88) pathway. MyD88 forms a complex with interleukin-1 receptor-associated kinases 1 and 4 (IRAK-4 and IRAK-1) and TRAF6. Next, this complex can activate the transcription factor IRF7 [3,23,24] ( Figure 1A) . can sense viral molecules in the cytoplasm. RIG-I exposes its caspase activation and recruitment domains (CARD) upon binding of short RNAs containing 5′-triphosphate ends and polyuridine-rich sequences [25] . CARD can bind to the adaptor protein mitochondrial antiviral signalling (MAVS), which interacts with TRAF3 and TRAF2/6, thereby converging on TLR3 pathways. The binding of RIG-I to MAVS is further promoted by polyubiquitination of the CARD domain and subsequent tetramerisation of RIG-I. As described above, TRAF3 triggers TBK1 and IKKε to phosphorylate IRF3 and IRF7, after which the transcription factors translocate to the nucleus. Signalling via TRAF2/6 results in the activation of NF-κB [24,26] ( Figure 1A ). MDA5 is thought to trigger the same signalling cascade as RIG-I, except that MDA5 is activated by long dsRNA [24] [25] [26] . IRFs are essential for the induction of IFNα/β and IFNλ, while NF-κB is thought to be required as a co-factor. The expression of interferons in the early stage of viral infection is mainly dependent on IRF3, which is constitutively expressed. IFNs then trigger the transcription of IRF7 which can serve to amplify the IFN response [5, 24] .">
    <entity charOffset="0-7" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e0" ontology_id="GO_0005634" text="nucleus" type="gene_function"/>
    <entity charOffset="427-445" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e1" ontology_id="GO_0006919" text="caspase activation" type="gene_function"/>
    <entity charOffset="482-489" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e2" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="611-624" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" ontology_id="HP_0001427" text="mitochondrial" type="phenotype"/>
    <entity charOffset="635-645" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e4" ontology_id="GO_0023052" text="signalling" type="gene_function"/>
    <entity charOffset="735-742" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e5" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="897-901" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e6" ontology_id="GO_0008384" text="TBK1" type="gene_function"/>
    <entity charOffset="1000-1007" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e7" ontology_id="GO_0005634" text="nucleus" type="gene_function"/>
    <entity charOffset="1009-1019" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e8" ontology_id="GO_0023052" text="Signalling" type="gene_function"/>
    <entity charOffset="1126-1136" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e9" ontology_id="GO_0023052" text="signalling" type="gene_function"/>
    <entity charOffset="1379-1394" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e10" ontology_id="GO_0016032" text="viral infection" type="gene_function"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e0" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p0" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e1" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p1" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e2" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p2" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e4" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p3" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e5" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p4" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e6" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p5" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e7" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p6" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e8" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p7" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e9" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p8" relation="true"/>
    <pair e1="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e3" e2="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.e10" id="cb2653d6bccc8ea8da3bb3abef1840d3ba2b9701.c3.p9" relation="true"/>
  </chunk>
</document>
